Clinical Trial Update: Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating post-transplant cyclophosphamide as GVHD prophylaxis versus standard of care in acute leukemia patients in remission. The study in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid Leukemia (AML) in Remission | Phase 3 | Status: RECRUITING